<?xml version="1.0" encoding="UTF-8"?>
<svg height="905.133" width="585.4196815714286" xmlns="http://www.w3.org/2000/svg">
 <g style="fill:none;">
  <text svg_rhmargin="102.103" x="76.272,81.588,85.127,89.558,92.802,95.902,99.003,102.103" y="21.089000000000055" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">Cancers </text>
  <text x="104.096,108.081,112.066,116.051" y="21.089000000000055" svg_rhmargin="120.036" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:7.97px;font-style:NORMAL;font-weight:BOLD;">2019</text>
  <text svg_rhmargin="122.029" x="120.036,122.029" y="21.089000000000055" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="124.021,128.006" y="21.089000000000055" svg_rhmargin="131.991" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:7.97px;font-style:italic;font-weight:normal;">11</text>
  <text x="131.991,133.984,135.976,139.961,143.94600000000003,491.809,495.794,499.779,501.772,506.123,508.777,510.77,514.755" y="21.089000000000055" svg_rhmargin="518.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.97px;font-style:NORMAL;font-weight:normal;">, 47 17 of 27</text>
  <text x="38.152,44.549,48.812,54.146,58.054,61.79,65.526,69.261" y="28.25400000000002" svg_rhmargin="71.655" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:9.58px;font-style:ITALIC;font-weight:normal;">Cancers </text>
  <text x="71.631,76.456,81.28,86.104" y="28.25400000000002" svg_rhmargin="90.892" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:9.58px;font-style:NORMAL;font-weight:bold;">2018</text>
  <text x="90.927,93.303" y="28.25400000000002" svg_rhmargin="95.697" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.58px;font-style:NORMAL;font-weight:normal;">, </text>
  <text x="95.678,100.503" y="28.25400000000002" svg_rhmargin="105.291" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:9.58px;font-style:ITALIC;font-weight:normal;">10</text>
  <text x="105.326,107.724,110.1,115.045,117.43900000000001,541.143,545.965,548.341,553.604,556.771,559.147,563.97,568.792" y="28.25400000000002" svg_rhmargin="571.186" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:9.58px;font-style:NORMAL;font-weight:normal;">, x 8 of 29 </text>
  <text style="fill:#000000;font-family:IKMAII+TimesNewRoman;font-size:10.8px;font-style:NORMAL;font-weight:normal;" svg_rhmargin="40.852" y="543.054" x=""/>
  <text y="543.054" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;" svg_rhmargin="503.038" x=""/>
  <text x="63.64,69.667,73.265,79.27,85.87,90.073,95.474,98.282,103.683" y="562.638" svg_rhmargin="106.383" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:10.8px;font-style:NORMAL;font-weight:bold;">Figure 4.</text>
  <text y="562.638" svg_rhmargin="371.918" x="109.216,115.846,122.141,127.324,130.132,133.66,139.566,143.841,149.024,153.613,157.144,159.952,166.452,169.605,175.511,178.965,183.554,186.362,192.269,195.875,198.61,208.117,213.301,216.831,222.241,225.847,231.257,237.552,242.962,246.114,252.089,256.678,259.83,264.419,267.155,272.564,278.547,284.453,290.933,294.464,297.272,304.904,310.593,317.202,324.426,327.234,332.644,338.939,345.548,348.356,355.58,362.804,365.514,368.322" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.8px;font-style:NORMAL;font-weight:normal;">The forest plots of meta-analysis about CSER and RR: (</text>
  <text x="371.799" y="562.638" svg_rhmargin="377.199" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:10.8px;font-style:NORMAL;font-weight:bold;">a</text>
  <text x="377.199,380.796,383.604,389.608,395.505,399.771,404.944,409.524,413.044,415.852,422.343,425.486,431.383,434.904,437.712,441.308,447.205,451.471,454.279,461.936,469.15,474.82,477.628,481.804,487.204,490.724,495.898,498.706,504.106,510.391,516.99,519.798,527.455,531.095,533.903,537.046,543.331" y="562.638" svg_rhmargin="546.031" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.8px;font-style:NORMAL;font-weight:normal;">) Forest plot for CRS rate and CI in </text>
  <text x="63.64,68.227,74.133,77.284,80.381,86.988,89.652,95.061,101.355,107.909,110.573,116.867,122.049,131.555,136.883,140.412,146.318,149.469,155.375,161.349,164.517,169.271,171.936,181.442,186.842,189.993,193.145,199.119,205.413,210.822,217.116,221.92,225.072,230.253,234.792,237.456,243.955,249.364,252.893,256.045,261.227,267.521,271.05,275.589,278.181,284.086,287.691,290.355,295.537,300.865,305.669,311.963,314.627,319.166,322.692,329.172,335.798,341.772,344.436,349.764,356.028,362.636,365.3,368.829,375.124,380.235,382.9,388.805,394.916,400.098,404.372,409.781,412.877,416.029,418.693,421.285" y="578.19" svg_rhmargin="424.881" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.8px;font-style:NORMAL;font-weight:normal;">solid and hematologic malignancies patients of each study and the overall; (</text>
  <text x="424.792" y="578.19" svg_rhmargin="431.391" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:10.8px;font-style:NORMAL;font-weight:bold;">b</text>
  <text x="431.415,434.999,437.663,443.655,449.539,453.792,458.952,463.518,467.026,469.69,476.168,479.298,485.182,488.69,491.282,494.865,500.749,505.002,507.666,516.628,522.285,524.95,529.203,534.59,538.098,543.258" y="578.19" svg_rhmargin="545.958" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.8px;font-style:NORMAL;font-weight:normal;">) Forest plot for NS rate </text>
  <text x="63.64,69.053,75.351,81.963,84.699,92.369,96.021,98.757,101.913,108.211,110.947,117.245,122.432,131.938,137.338,140.871,146.781,149.937,155.847,161.821,164.989,169.797,172.533,182.039,187.439,190.595,193.75,199.725,205.917,211.317,217.615,222.423,225.579,230.765,235.358,238.093,244.597,250.01,253.544,256.64,261.826,267.976,271.501,276.084,278.749,284.65,288.25,290.986,296.164,301.568,306.367,312.657,315.393,319.977,323.502,330.018,336.622,342.631,345.366,350.694,356.958,363.561,366.297,369.822,376.112,381.289,384.025,389.926,396.032,401.21,405.48,410.884,414.032,417.128,419.864,422.528" y="593.814" svg_rhmargin="426.124" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.8px;font-style:NORMAL;font-weight:normal;">and CI in hematologic malignancies patients of each study and the overall; (</text>
  <text x="426.16" y="593.814" svg_rhmargin="430.955" style="fill:#000000;font-family:IKLPOK+PalatinoLinotype,Bold;font-size:10.8px;font-style:NORMAL;font-weight:bold;">c</text>
  <text x="430.984,434.58,437.315,443.319,449.215,453.48,458.652,463.23,466.75,469.485,475.975,479.117,485.012,488.532,491.268,494.863,500.759,505.024,507.759,514.973,522.186,524.922,530.321,536.656,543.354" y="593.814" svg_rhmargin="546.054" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.8px;font-style:NORMAL;font-weight:normal;">) Forest plot for RR and </text>
  <text x="63.641,71.31,74.961,77.697,80.852,87.149,89.813,94.404,100.313,103.468,106.564,113.175,115.911,121.322,127.62,134.173,136.838,143.135,148.32,157.826,163.226,166.759,172.668,175.822,181.731,187.706,190.873,195.68,198.416,207.85,213.25,216.405,219.559,225.534,231.831,237.243,243.541,248.348,251.502,256.687,261.226,263.873,270.372,275.781,279.31,282.462,287.643,293.938,297.467,302.055,304.791,310.696,314.224,316.96,322.142,327.551,332.354,338.546,341.282,345.87,349.323,355.844,362.452,368.465,371.201,376.61,382.904,389.511,392.247,395.776,402.071,407.252,409.988,415.894,421.943,427.124,431.399,436.808,439.959,443.111" y="609.51" svg_rhmargin="445.811" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:10.8px;font-style:NORMAL;font-weight:normal;">CI in solid and hematologic malignancies patients of each study and the overall.</text>
  <text y="609.51" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:10.8px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="448.372" x=""/>
  <text x="38.152,44.165,47.117,53.13,56.137,59.089,70.441,75.047,79.052,84.392,88.352,97.062,103.749,109.007,112.351,118.364,123.042,126.386,131.065,134.089,139.429,142.772,145.796,153.818,161.839,164.863,170.203,173.547,176.499,184.52,193.202,201.224,204.248,211.595,214.619,221.888,227.936,232.615,237.293,242.551,248.527,254.575,257.599,260.943,267.63,270.582,277.929,283.269,287.275,290.618,295.297,301.919,305.924,310.602,313.554,322.192,325.506,329.511,335.524,338.476,345.163,350.503,353.847,357.19,363.204,366.228,371.568,378.189,384.202,387.154,396.51,401.189,410.545,415.884,419.89,425.23,428.573,433.831,439.845,443.189,448.084,451.035,462.387,467.727,471.071,474.415,480.428,487.115,492.454,499.076,503.975,507.319,511.997,516.603" y="639.75" svg_rhmargin="519.609" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:12.02px;font-style:ITALIC;font-weight:normal;">2.6. Meta-Analysis of RR of CAR T Therapy in Patients with Solid and Hematologic Malignancies </text>
  <text x="63.64,70.299,76.838,81.561,85.454,92.113,95.119,101.905,106.977,110.87,118.094,125.415,128.942,134.631,139.703,142.709,149.495,153.527,159.512,165.498,171.546,177.531,183.58,186.559,192.545,198.593,201.545,207.53,213.578,219.564,225.549,231.597,234.577,240.625,246.611,249.59,255.576,261.624,264.603,270.589,276.574,282.622,288.608,294.656,297.636,303.621,309.669,312.621,318.669,324.645,327.625,333.61,339.658,342.61,348.596,354.644,357.623,363.671,369.657,375.642,381.69,387.676,391.707,394.687,397.693,404.407,407.935,414.919,420.231,423.759,430.983,438.303,441.831,448.814,455.473,458.479,465.193,471.241,477.217,483.265,486.27099999999996,492.985,500.185,506.234,510.127,513.655,519.388,526.359,530.253,535.324,538.3299999999999,545.117,555.118,562.09,568.715" y="663.078" svg_rhmargin="571.721" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">Forty studies [15–19,22,25–27,30,31,34–52,54,55,57,58,60–65], including 533 patients who </text>
  <text x="38.152,44.2,49.53,56.507,60.035,65.774,72.547,78.287,85.613,88.619,89.357,95.902,102.675,108.414,113.143,119.191,122.647,126.174,129.18,129.919,134.648,140.387,145.465,152.671,159.215,166.193,171.271,177.01,180.016,180.682,186.73,190.761,194.661,200.4,205.129,208.135,208.873,212.773,217.502,223.241,229.289,233.188,243.785,249.524,256.501,260.401,263.386,266.392,267.131,277.138,282.877,287.606,293.345,296.351,297.018,302.757,306.207,309.737,316.431,319.91,326.539,330.068,335.829,338.835,339.573,343.606,350.088,354.817,357.823,358.561,362.461,369.438,375.177,378.183,378.849,386.861,394.927,397.933,398.671,404.41,411.107,417.156,420.613,427.843,433.893,437.792,441.321,447.866,454.843,457.849,458.515,465.06,469.093,472.099,472.837,481.342,490.676,498.742,501.748,502.486,509.762,512.768,513.506,517.405,524.383,530.122,534.851,540.9,548.1,554.765,557.771,558.437,561.966,568.879" y="679.278" svg_rhmargin="571.885" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">achieved overall response after treatment, were eligible for the RR evaluation of CAR T therapy in </text>
  <text x="38.152,45.35,51.398,55.291,58.818,64.55,71.521,75.413,80.483,83.489,85.667,95.667,99.195,103.087,110.058,113.06400000000001,115.241,120.312,126.849,130.32,133.848,141.167,144.173,146.279,152.327,159.31,166.629,169.635,171.813,178.783,184.515,195.104,201.153,205.045,211.582,215.11,221.663,228.321,231.849,237.16,240.166,242.271,252.861,258.909,262.38,265.908,272.565,279.536,285.584,292.567,297.878,301.406,307.138,312.209,315.187,318.193,320.37,327.714,334.684,340.416,343.42199999999997,345.599,352.137,358.903,364.634,369.356,375.404,378.86,382.388,385.39399999999995,387.499,394.698,401.235,407.773,411.301,417.032,424.351,427.35699999999997,429.463,437.467,445.532,448.53799999999995,450.644,456.629,463.599,470.918,473.924,476.102,482.086,488.134,498.207,501.21299999999997,503.39,511.887,515.912,518.918,521.095,525.127,529.807,536.344,546.934,549.9399999999999,552.117,556.009,562.98,568.712" y="695.478" svg_rhmargin="571.718" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">patients with solid and hematologic malignancies. The overall pooled RR and 95% CI from the </text>
  <text x="38.152,41.679,48.663,55.986,59.513,66.21,69.737,77.06,84.287,90.335,93.79,96.814,101.888,105.702,112.929,120.252,123.779,129.467,134.541,137.565,147.569,153.304,158.03,163.765,166.717,172.705,178.693,188.769,191.793,195.773,201.821,207.869,217.879,220.903,229.404,233.432,236.414,239.438,245.426,251.414,257.462,263.45,269.498,279.574,283.606,286.558,290.59,297.283,300.758,307.42,314.646,319.371,325.107,328.131,334.179,339.437,343.469,346.421,349.445,359.449,362.977,366.872,373.846,376.798,382.786,385.81,390.884,394.359,401.02,407.994,411.522,415.482,419.01,424.268,430.316,437.299,441.195,444.219,451.193,456.929,460.824,466.56,471.285,477.826,484.488,490.223,497.197,502.932,506.46,510.346,517.008,520.032,524.063" y="711.678" svg_rhmargin="528.115" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">individual studies were 29% (95% CI: 21–38%) (Figure 4c), with a significant heterogeneity (I</text>
  <text x="528.112" y="708.654" svg_rhmargin="531.712" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:7.2px;font-style:NORMAL;font-weight:normal;">2</text>
  <text y="711.678" svg_rhmargin="571.8" x="534.591,540.64,543.591,549.567,555.615,565.752,568.794" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">= 53%, </text>
  <text x="38.152" y="727.878" svg_rhmargin="44.164" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:12.02px;font-style:ITALIC;font-weight:normal;">p</text>
  <text y="727.878" svg_rhmargin="571.894" x="47.728,53.754,57.282,63.308,66.26,72.236,78.284,82.303,85.255,88.855,96.24,103.252,108.939,112.539,117.303,123.33,130.342,137.703,144.283,154.797,158.815,164.502,168.521,172.539,178.226,183.58,187.466,191.066,201.652,208.205,215.566,221.34,224.853,228.453,238.39,244.438,249.479,253.079,260.344,265.457,271.146,278.491,282.091,285.977,292.53,296.13,301.388,307.436,310.95,316.208,323.473,326.929,332.955,336.841,342.615,346.215,350.101,357.085,362.859,373.445,376.465,380.065,387.34,394.323,400.097,403.697,408.81,416.075,422.624,429.318,434.082,440.661,447.926,455.053,458.581,464.607,471.619,477.595,481.123,487.745,492.859,496.372,501.414,505.014,511.593,515.553,519.153,524.265,530.746,534.26,537.773,545.046,548.646,554.673,561.685,568.888" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">&lt; 0.01). The random-effect model was used to calculate them. The subgroup analysis of solid and </text>
  <text x="38.152,45.133,50.876,61.476,67.524,71.427,77.975,81.457,88.006,94.674,98.156,103.478,106.502,117.103,123.151,126.633,130.115,136.783,143.765,149.813,156.796,162.118,165.6,171.343,176.424,179.448,184.53,191.511,198.059,208.07,213.813,221.143,224.239,228.142,235.123,241.171,245.057,248.153,251.967,258.951,264.694,267.79,275.805,283.82,286.916,293.465,297.452,300.52,307.752,313.768,317.582,321.038,326.802,333.805,337.691,342.805,345.901,355.934,359.438,363.324,370.236,373.332,380.335,386.022,396.644,402.661,406.547,413.1,416.604,423.174,429.795,433.323,438.666,441.763,452.276,458.252,461.756,465.26,471.95,478.862,484.91,491.912,497.171,500.674,506.439,511.48,514.576,518.536,524.512,530.488,540.57,543.581,546.605,552.622,558.638,568.743" y="744.078" svg_rhmargin="571.749" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">hematologic malignancies showed that the RR of patients with hematologic malignancies (29%, 95% </text>
  <text x="38.152,46.656,50.688,53.674,56.698,62.689,68.737,74.729,80.72,86.768,96.848" y="760.206" svg_rhmargin="100.852" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">CI: 20–40%)</text>
  <text y="760.206" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:12.02px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="103.798" x=""/>
  <text x="103.744,113.75,119.798,124.875,127.827,132.903,136.431,146.945,150.473,153.95,159.998,164.726,167.75,171.564,178.117,181.141,188.346,194.394,198.292,201.82,207.558,214.534,218.432,223.509,226.461,236.467,239.995,243.809,250.793,253.817,258.893,265.437,268.914,272.442,279.767,282.791,293.305,299.353,302.83,306.358,313.022,319.998,326.046,333.03,338.347,341.874,347.612,352.689,355.641,359.672,365.648,371.696,381.779,384.763,387.787,393.777,399.825,409.904,412.928,421.431,425.462,428.446,431.398,437.388,443.436,449.427,455.417,461.465,471.544,475.526,478.51" y="760.206" svg_rhmargin="481.516" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">was similar to patients with solid malignancies (27%, 95% CI: 13–48%). </text>
  <text x="38.152,44.16,47.163,53.171,56.173,59.125,65.807,71.142,77.824,82.497,87.325,91.999,96.673,99.697,105.032,108.371,111.323,120.674,125.347,129.348,134.022,138.695,143.953,149.962,154.635,161.257,165.936,169.275,173.275,179.283" y="790.806" svg_rhmargin="182.289" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:12.02px;font-style:ITALIC;font-weight:normal;">2.7. Sources of Heterogeneity </text>
  <text x="63.64,71.019,78.026,83.794,87.034,94.041,99.808,103.695,109.454,114.212,120.786,127.479,133.168,140.174,145.942,149.45,153.336,160.029,163.198,169.218,176.13,182.15,185.657,192.279,197.393,200.849,205.89,209.131,213.889,219.657,224.698,231.97,235.478,239.364,244.406,247.646,252.753,259.759,266.332,276.269,282.037,289.392,292.633,296.519,303.502,309.523" y="814.206" svg_rhmargin="313.443" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">The heterogeneity analysis results showed that</text>
  <text y="814.206" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:12.02px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="316.27" x=""/>
  <text x="316.505,323.51,329.277,333.163,338.923,343.602,350.155,356.848,362.615,369.62,375.387,378.893,382.779,389.4,392.641,398.617,402.145,407.25,413.731,416.899,422.666,428.878,432.384,437.489,441.375,447.135,454.408,457.649,461.155,468.066,471.307,477.879,481.765,488.677,494.436,499.193,502.361,506.372,512.392,517.737,521.624,528.196,532.953,537.994,541.018,544.187,549.292,556.55,561.808,568.791" y="814.206" svg_rhmargin="571.797" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">heterogeneity also existed in other factors, such </text>
  <text x="38.153,44.201,49.315,52.339,57.651,63.384,66.857,70.384,73.408,78.721,85.945,89.473,93.359,100.583,105.306,111.039,114.063,124.064,127.592,131.486,138.457,141.481,145.375,152.346,158.079,161.031,167.079,174.425,181.745,185.273,189.166,192.694,199.233,206.204,209.228,215.767,219.798,222.822,226.848,234.168,238.146,244.194,247.173,250.125,257.47,263.518,270.141,273.668,279.401,282.353,288.401,291.305,296.403,303.654,314.167,324.753,330.765,335.515,339.014,345.026,350.785,358.059,361.083,365.003,372.0,377.76,380.784,385.464,391.223,396.321,403.521,407.02,410.94,416.038,419.062,425.627,429.631,432.655,443.273,449.032,452.952,458.964,462.968,467.717,473.477,480.162,484.912,490.599,495.697,500.739,504.238,510.803,517.801,520.753,526.765,533.763,539.775,543.274,549.896,555.009,558.508,563.607,566.558" y="830.405" svg_rhmargin="569.564" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">as cell culture with the addition of IL-2. Table 3 summarized the results of meta-regression analysis. </text>
  <text x="63.641,71.007,78.0,83.755,86.761,87.787,92.531,98.286,103.38,110.625,114.119,118.034,121.04,122.066,128.547,132.579,135.585,136.538,147.151,152.905,156.82,162.827,166.827,171.571,177.326,183.948,188.692,194.447,199.54,204.634,208.128,214.688,221.681,224.687,225.713,231.72,238.632,244.639,248.133,254.814,259.907,263.401,268.494,271.5,272.526,279.076,284.835,288.75,298.773,304.528,310.283,317.276,320.282,321.257,327.82,334.611,340.368,345.115,351.124,354.621,358.118,361.12399999999997,362.077,366.824,372.581,377.677,384.901,391.464,398.459,403.555,409.243,412.24899999999997,413.202,419.212,426.207,433.551,436.55699999999996,437.583,444.927,448.424,452.426,456.427,462.115,466.862,472.619,479.614,483.532,486.53799999999995,487.563,491.565,497.575,502.911,506.828,513.391,518.138,523.234,526.24,527.193,532.289,539.285,545.847,555.873,561.561,568.907" y="846.605" svg_rhmargin="571.913" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">The result of meta-regression analysis between overall response and different factors showed </text>
  <text x="38.153,42.05,49.025,55.073,58.959,61.263,70.691,78.756" y="862.805" svg_rhmargin="86.788" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">that ORR</text>
  <text y="862.805" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:12.02px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="89.759" x=""/>
  <text x="89.057,96.255,101.007,106.777,111.819,117.589,124.598,128.484,134.244,141.601,143.905,149.928,152.16,157.269,160.778,167.475,174.386,177.896,181.855,185.311,190.641,196.664,203.673,207.559,209.863,215.839,220.948,226.057,232.633,237.982,241.438,247.461,251.347,254.802,261.356,268.364,273.473,275.777,285.816,289.326,293.212" y="862.805" svg_rhmargin="300.21" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">presented a significant associations with</text>
  <text y="862.805" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:12.02px;font-style:ITALIC;font-weight:normal;" svg_rhmargin="303.167" x=""/>
  <text x="302.392,308.419,312.485,319.846,323.806,329.832,332.064,338.09,345.452,352.813,356.326,360.14,363.668,370.247,377.26,383.286,385.518" y="862.805" svg_rhmargin="389.522" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">“IL-2 addition” (</text>
  <text x="389.44" y="862.805" svg_rhmargin="395.452" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:12.02px;font-style:ITALIC;font-weight:normal;">p</text>
  <text y="862.805" svg_rhmargin="568.832" x="397.72,403.745,405.977,412.002,414.954,420.979,426.955,432.931,438.979,442.939,445.963,448.266,457.634,464.546,471.906,474.209,478.096,485.079,490.852,493.156,497.918,503.691,508.733,516.005,519.517,523.403,525.707,532.285,536.245,538.549,549.135,554.894,558.78,564.828" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">= 0.0176). And the result of meta-</text>
  <text x="38.152,42.896,48.651,55.332,60.076,65.831,70.873,75.966,79.46,86.02,92.932,95.938,99.339,105.347,112.34,118.347,121.841,128.463,133.577,137.071,142.164,145.17,148.644,155.288,161.043,164.958,174.895,180.649,186.404,193.397,196.403,199.877,205.211,211.771,222.384,229.605,233.099,238.854,242.769,248.458,251.464,254.937,259.682,265.437,270.53,277.752,284.312,291.223,296.317,302.104,305.10999999999996,308.511,314.516,321.428,328.767,331.77299999999997,335.247,342.52,346.048,350.045,354.042,359.794,364.536,370.288,377.279,381.192,384.198,387.599,391.596,397.601,402.932,406.845,413.403,418.145,423.236,426.24199999999996,429.716,434.807,441.797,448.355,458.376,464.064,471.409,474.41499999999996,477.889,481.801,488.792,494.797,498.709,501.715,505.189,513.613,521.606,529.63,532.636,536.038,543.029,549.034,556.307,559.313,562.786,568.791" y="879.005" svg_rhmargin="571.797" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">regression analysis between complete response and different factors showed that CRR had a </text>
  <text x="38.152,43.26,46.768,53.463,60.374,63.883,67.843,71.351,76.699,82.721,89.729,93.543,96.549,98.654,104.63,109.672,114.779,121.354,126.702,130.158,136.18,140.066,143.575,150.149,157.157,162.199,165.205,167.31,177.348,180.803,184.689,191.673,194.679,196.784,202.806,206.692,213.267,217.153,223.175,226.63,229.636,231.671,237.693,244.966,255.552,259.08,266.087,269.596,274.704,278.59,283.27,289.318,293.204,296.732,303.306,310.314,313.32,315.354,322.711,329.285,334.393,340.162" y="895.133" svg_rhmargin="346.174" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">significant associations with “total administration dose”</text>
  <text svg_rhmargin="364.15" y="895.133" x="351.136,355.168,361.144,364.15" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:12.02px;font-style:ITALIC;font-weight:normal;">(p </text>
  <text x="366.185,372.233,375.239,377.273,383.321,386.273,392.321,398.297,404.273" y="895.133" svg_rhmargin="410.285" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">= 0.0067</text>
  <text x="410.321" y="895.133" svg_rhmargin="414.325" style="fill:#000000;font-family:IKLPOI+PalatinoLinotype,Italic;font-size:12.02px;font-style:ITALIC;font-weight:normal;">)</text>
  <text x="414.281,417.3,420.306,422.411,434.448,441.36,447.133,454.144,457.15,459.184,465.209,469.275,476.635,480.594,486.57,489.57599999999996,491.681,497.707,504.98,512.34,515.852,519.738,523.266,529.747,536.731,542.756,545.762,547.867,557.804,563.852,568.821" y="895.133" svg_rhmargin="571.827" style="fill:#000000;font-family:IKLPLH+PalatinoLinotype;font-size:12.02px;font-style:NORMAL;font-weight:normal;">. When “IL-2 addition” was </text>
  <rect style="stroke:blue;stroke-width:0.3;" x="106.912" y="45.534" height="497.52" width="393.12" title="17"/>
  <text x="106.912" y="45.534" class="image" id="image.17.1" width="393" height="497">image.17.1.107_500.46_543</text>
  <text svg_rhmargin="133.168" x="97.795,102.78,105.766,110.751,116.23,119.718,124.20100000000001,126.443,130.926,133.16799999999998" y="561.017" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">Figure 4. </text>
  <text x="135.942,141.488,146.753,151.087,153.321,156.334,161.274,164.694,169.018,172.854,175.80300000000003,178.047,183.484,186.117,191.057,194.006,197.842,200.077,205.017,208.03,210.273,218.262,222.595,225.544,230.068,233.081,237.604,242.87,247.393,250.026,255.056,258.883,261.516,265.35200000000003,267.595,272.119,277.122,282.062,287.517,290.466,292.701,299.115,303.865,309.393,315.436,317.68,322.204,327.469,332.997,335.231,341.275,347.318,349.58,351.815" y="561.017" svg_rhmargin="354.828" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">The forest plots of meta-analysis about CSER and RR: (</text>
  <text x="354.83" y="561.017" svg_rhmargin="359.313" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">a</text>
  <text x="359.313,362.32599999999996,364.56,369.59,374.53,377.95,382.284,386.12,389.069,391.303,396.741,399.374,404.313,407.262,409.497,412.51,417.45,421.024,423.267,429.681,435.725,440.475,442.709,446.283,450.806,453.756,458.09,460.324,464.847,470.113,475.641,477.884,484.299,487.34799999999996,489.582,492.215" y="561.017" svg_rhmargin="497.48" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">) Forest plot for CRS rate and CI in</text>
  <text x="97.795,101.601,106.501,109.113,111.725,117.20899999999999,119.453,123.94,129.164,134.648,136.892,142.115,146.415,154.34,158.827,161.753,166.654,169.266,174.166,179.157,181.769,185.75400000000002,187.997,195.923,200.41,203.022,205.634,210.624,215.848,220.336,225.559,229.544,232.156,236.455,240.26000000000002,242.505,247.899,252.387,255.313,257.924,262.224,267.447,270.373,274.178,276.423,281.323,284.31199999999995,286.556,290.855,295.343,299.328,304.551,306.795,310.601,313.527,318.939,324.423,329.413,331.657,336.145,341.368,346.852,349.096,352.022,357.246,361.54499999999996,363.789,368.689,373.76,378.06,381.605,386.093,388.704,391.316,393.56,395.804" y="573.8389999999999" svg_rhmargin="398.793" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">solid and hematologic malignancies patients of each study and the overall; (</text>
  <text x="398.793" y="573.8389999999999" svg_rhmargin="404.271" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">b</text>
  <text x="404.271,407.26,409.504,414.494,419.394,422.778,427.077,430.883,433.80899999999997,436.053,441.447,444.059,448.959,451.885,454.129,457.118,462.018,465.563,467.807,475.266,479.978,482.222,485.767,490.255,493.181" y="573.8389999999999" svg_rhmargin="497.48" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">) Forest plot for NS rate</text>
  <text x="97.795,102.305,107.555,113.066,115.303,121.699,124.739,126.975,129.6,134.85,137.096,142.346,146.666,154.631,159.132,162.073,166.998,169.623,174.548,179.563,182.188,186.19299999999998,188.439,196.404,200.914,203.539,206.164,211.179,216.429,220.939,226.189,230.194,232.818,237.139,240.96300000000002,243.201,248.622,253.132,256.072,258.697,263.018,268.268,271.208,275.03200000000004,277.27,282.195,285.199,287.436,291.756,296.266,300.271,305.521,307.758,311.583,314.523,319.962,325.474,330.489,332.726,337.236,342.486,347.997,350.234,353.175,358.425,362.74600000000004,364.991,369.916,375.013,379.333,382.896,387.407,390.031,392.656,394.911,397.148" y="586.6610000000001" svg_rhmargin="400.152" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">and CI in hematologic malignancies patients of each study and the overall; (</text>
  <text x="400.151" y="586.6610000000001" svg_rhmargin="404.132" style="fill:#000000;font-family:DPYECX+URWPalladioL-Bold;font-size:8.97px;font-style:NORMAL;font-weight:BOLD;">c</text>
  <text x="404.132,407.136,409.373,414.388,419.313,422.714,427.034,430.859,433.79999999999995,436.036,441.458,444.082,449.007,451.948,454.194,457.198,462.123,465.686,467.923,473.948,479.97299999999996,482.211,486.721,491.971" y="586.6610000000001" svg_rhmargin="497.482" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">) Forest plot for RR and</text>
  <text x="97.795,104.152,107.174,109.415,112.025,117.24300000000001,119.485,123.286,128.182,130.791,133.401,138.87900000000002,141.121,145.604,150.822,156.3,158.542,163.761,168.056,175.973,180.456,183.379,188.275,190.884,195.78,200.765,203.374,207.355,209.597,217.514,221.998,224.607,227.216,232.201,237.42,241.903,247.121,251.103,253.712,258.007,261.809,264.05,269.439,273.922,276.845,279.454,283.749,288.968,291.891,295.69300000000004,297.934,302.83,305.816,308.057,312.352,316.835,320.816,326.034,328.276,332.078,335.001,340.408,345.886,350.87100000000004,353.113,357.596,362.815,368.293,370.535,373.458,378.676,382.971,385.213,390.109,395.175,399.47,403.011,407.494,410.104,412.713" y="599.483" svg_rhmargin="414.955" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:8.97px;font-style:NORMAL;font-weight:normal;">CI in solid and hematologic malignancies patients of each study and the overall.</text>
  <text x="76.535,81.516,84.007,88.988,91.479,94.567,103.972,107.847,111.165,115.588,118.906,126.099,131.638,136.062,138.831,143.812,147.688,150.457,154.333,156.824,161.247,164.01700000000002,166.507,173.152,179.797,182.288,186.711,189.48100000000002,191.972,198.617,205.81,212.455,214.945,221.03199999999998,223.523,229.61,234.592,238.467,242.343,246.766,251.747,256.72900000000004,259.219,261.989,267.52799999999996,270.019,276.106,280.529,283.847,286.616,290.492,296.031,299.349,303.22499999999997,305.715,312.908,315.677,318.995,323.97700000000003,326.467,332.006,336.429,339.199,341.969,346.951,349.44,353.864,359.403,364.38500000000005,366.875,374.626,378.501,386.252,390.676,393.993,398.417,401.186,405.61,410.591,413.361,417.416,419.906,429.311,433.734,436.504,439.273,444.255,449.794,454.217,459.756,463.811,466.581,470.456" y="620.565" svg_rhmargin="474.331" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:9.96px;font-style:italic;font-weight:normal;">2.6. Meta-Analysis of RR of CAR T Therapy in Patients with Solid and Hematologic Malignancies</text>
  <text x="97.795,103.223,108.554,112.411,115.594,121.02199999999999,123.336,127.476,130.658,136.546,142.511,145.352,150.029,154.16899999999998,156.482" y="640.052" svg_rhmargin="159.733" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">Forty studies [</text>
  <text x="159.734,164.715" y="640.052" svg_rhmargin="169.696" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">15</text>
  <text x="169.696" y="640.052" svg_rhmargin="174.578" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="174.578,179.559" y="640.052" svg_rhmargin="184.54" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">19</text>
  <text x="184.541" y="640.052" svg_rhmargin="186.982" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="186.982,191.963" y="640.052" svg_rhmargin="196.944" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">22</text>
  <text x="196.944" y="640.052" svg_rhmargin="199.385" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="199.385,204.366" y="640.052" svg_rhmargin="209.347" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">25</text>
  <text x="209.348" y="640.052" svg_rhmargin="214.23" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="214.229,219.21" y="640.052" svg_rhmargin="224.191" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">27</text>
  <text x="224.192" y="640.052" svg_rhmargin="226.633" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="226.633,231.614" y="640.052" svg_rhmargin="236.595" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">30</text>
  <text x="236.596" y="640.052" svg_rhmargin="239.037" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="239.036,244.017" y="640.052" svg_rhmargin="248.998" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">31</text>
  <text x="248.999" y="640.052" svg_rhmargin="251.44" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="251.44,256.421" y="640.052" svg_rhmargin="261.402" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">34</text>
  <text x="261.403" y="640.052" svg_rhmargin="266.285" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="266.284,271.265" y="640.052" svg_rhmargin="276.246" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">52</text>
  <text x="276.247" y="640.052" svg_rhmargin="278.688" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="278.688,283.669" y="640.052" svg_rhmargin="288.65" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">54</text>
  <text x="288.65" y="640.052" svg_rhmargin="291.091" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="291.091,296.072" y="640.052" svg_rhmargin="301.053" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">55</text>
  <text x="301.054" y="640.052" svg_rhmargin="303.495" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="303.495,308.476" y="640.052" svg_rhmargin="313.457" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">57</text>
  <text x="313.457" y="640.052" svg_rhmargin="315.898" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="315.898,320.879" y="640.052" svg_rhmargin="325.86" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">58</text>
  <text x="325.861" y="640.052" svg_rhmargin="328.302" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">,</text>
  <text x="328.302,333.283" y="640.052" svg_rhmargin="338.264" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">60</text>
  <text x="338.264" y="640.052" svg_rhmargin="343.146" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">–</text>
  <text x="343.146,348.127" y="640.052" svg_rhmargin="353.108" style="fill:#0875b7;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">65</text>
  <text x="353.109,356.36,358.801,361.154,363.995,369.677,374.012,376.853,382.741,388.706,391.547,397.23,402.658,404.972,409.854,414.735,419.617,421.931,427.799,432.68,435.863,438.704,443.381,449.063,452.246,456.38599999999997,458.7,466.842,472.525,477.856,480.169,485.051,489.386,495.068,497.909,502.586,508.102,512.779" y="640.052" svg_rhmargin="518.744" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">], including 533 patients who achieved</text>
  <text x="76.535,82.083,87.825,92.692,96.706,101.787,104.744,107.701,110.679,114.51,119.377,123.686,129.793,135.342,141.256,145.564,150.432,153.409,158.49,161.874,165.187,170.055,174.06900000000002,177.046,180.359,184.2,189.067,194.148,197.461,206.434,211.301,217.216,220.528,223.069,226.168,234.643,239.511,243.342,248.21,251.187,256.054,259.011,261.968,267.618,270.576,276.195,279.152,284.02,286.997,290.381,295.929,299.943,302.921,306.233,312.148,317.016,319.993,326.781,333.569,336.546,341.414,347.155,352.236,355.193,361.321,366.402,369.715,372.672,378.22,384.134,387.112,392.66,396.04400000000004,399.021,406.226,414.132,420.92,423.898,430.127,433.104,436.417,442.331,447.199,451.213,456.294,462.401,468.051,471.028,473.985,479.899,482.877,488.984,494.065,497.378,500.335,505.202,511.117,514.429" y="653.561" svg_rhmargin="518.738" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">overall response after treatment, were eligible for the RR evaluation of CAR T therapy in patients</text>
  <text x="76.117,84.592,87.549,90.862,96.776,99.753,104.062,109.61,112.568,115.525,121.73400000000001,124.711,129.792,135.706,141.915,144.892,150.807,155.674,164.647,169.728,173.041,178.589,181.546,187.095,192.745,195.702,200.214,203.201,212.174,217.255,220.212,223.169,228.819,234.733,239.814,245.728,250.24,253.197,258.065,262.374,264.915,269.467,275.696,281.61,286.478,289.455,295.003,300.745,305.612,309.626,314.707,317.664,320.621,323.599,329.706,335.254,340.803,343.76,348.627,354.836,357.814,364.602,371.39,374.367,379.448,385.362,391.571,394.549,399.63,404.711,413.247,416.234,423.439,426.86400000000003,429.841,433.225,437.056,442.604,451.577,454.554,457.867,463.781,468.649,471.626,474.583,480.498,486.707,489.664,495.405,498.362,504.571,510.699,515.78" y="667.071" svg_rhmargin="518.737" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">with solid and hematologic malignancies. The overall pooled RR and 95% CI from the individual</text>
  <text x="76.535,80.844,84.156,90.284,96.493,99.45,104.318,108.627,111.156,119.631,124.499,128.33,133.198,135.738,140.819,145.9,154.436,156.966,160.35,165.431,170.512,179.048,181.578,188.783,192.207,194.748,197.278,202.359,207.44,212.521,217.602,222.683,231.219,234.60299999999998,237.133,240.517,246.167,249.124,254.774,260.902,264.733,269.601,272.141,277.221,281.733,285.117,287.658,290.198,298.673,301.63,304.943,310.85699999999997,313.388,318.469,320.999,325.307,328.264,333.914,339.829,342.786,348.934,353.446,358.526,364.441,367.75399999999996,370.284,376.198,381.065,384.378,389.246,393.077,398.625,404.275,409.143,415.057,419.924,422.881,426.194,431.844,434.374,437.758" y="680.58" svg_rhmargin="441.183" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">studies were 29% (95% CI: 21–38%) (Figure 4c), with a signiﬁcant heterogeneity (I</text>
  <text svg_rhmargin="444.974" x="441.188,444.974" y="680.58" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:7.57px;font-style:NORMAL;font-weight:normal;">2 </text>
  <text svg_rhmargin="477.93" x="448.004,454.16200000000003,456.692,461.773,466.854,475.39,477.931" y="680.58" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">= 53%, </text>
  <text svg_rhmargin="485.555" x="480.474,485.555" y="680.58" style="fill:#000000;font-family:AKYTAJ+URWPalladioL-Ital;font-size:9.96px;font-style:italic;font-weight:normal;">p </text>
  <text x="488.086,494.244,496.774,501.855,504.396,509.477,514.558,517.942" y="680.58" svg_rhmargin="520.482" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">&lt; 0.01).</text>
  <text x="76.226,82.235,87.941,92.637,95.117,98.989,103.891,109.596,115.586,120.938,129.595,132.859,137.555,140.643,143.907,148.603,152.956,156.152,158.632,167.288,172.64,178.63,183.326,186.179,188.649,196.825,201.727,205.883,208.363,214.275,218.431,223.127,229.11700000000002,231.597,234.793,240.145,242.626,246.978,251.88,254.732,259.085,264.996,267.849,272.751,275.947,280.64300000000003,283.122,286.318,292.024,296.72,305.376,307.827,310.905,316.914,322.62,327.31600000000003,329.796,333.952,339.863,345.285,350.735,354.431,359.784,365.695,371.587,374.067,378.968,384.674,389.575,392.428,397.879,402.035,404.888,409.044,411.515,416.868,420.132,422.612,426.769,432.121,434.974,437.827,443.817,446.297,451.198,456.904,462.894,465.374,471.079,475.775,484.431,489.333,492.529,497.881,500.734,506.086,511.537,514.39" y="694.09" svg_rhmargin="518.743" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">The random-effect model was used to calculate them. The subgroup analysis of solid and hematologic</text>
  <text x="76.535,85.446,90.492,93.429,96.366,101.977,107.851,112.897,118.771,123.251,126.188,131.022,135.301,137.804,142.083,147.957,153.467,161.884,166.718,172.884,175.377,178.667,184.541,189.587,192.87699999999998,195.38,198.67,204.543,209.377,211.88,218.622,225.363,227.856,233.366,236.727,239.23,245.295,250.341,253.631,256.568,261.402,267.276,270.566,274.84499999999997,277.348,285.765,288.701,291.991,297.865,300.358,306.231,311.066,319.977,325.023,328.313,333.823,336.76,342.27,347.882,350.818,355.299,357.802,366.713,371.76,374.696,377.633,383.244,389.118,394.164,400.038,404.518,407.455,412.289,416.568,419.061,422.422,427.468,432.514,440.991,443.514,446.017,451.063,456.109,464.58599999999996,467.09,474.245,477.646,480.16900000000004,482.672,487.718,492.764,497.81,502.856,507.902,516.379" y="707.599" svg_rhmargin="519.74" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">malignancies showed that the RR of patients with hematologic malignancies (29%, 95% CI: 20–40%)</text>
  <text x="76.117,84.426,89.407,93.631,96.122,100.346,103.245,112.042,114.941,117.84,122.822,126.757,129.248,132.495,137.935,140.426,146.413,151.394,154.642,157.541,162.313,168.112,171.359,175.583,178.074,186.383,189.282,192.53,198.328,200.819,205.043,210.482,213.382,216.281,222.368,224.859,233.656,238.637,241.536,244.435,249.974,255.772,260.754,266.552,270.975,273.875,278.647,282.871,285.361,288.679,293.66,298.642,307.01,309.501,311.991,316.973,321.954,330.323,332.813,339.877,343.234,345.72499999999997,348.215,353.197,358.178,363.159,368.141,373.122,381.491,384.808" y="721.108" svg_rhmargin="387.299" style="fill:#000000;font-family:MSSLTZ+URWPalladioL-Roma;font-size:9.96px;font-style:NORMAL;font-weight:normal;">was similar to patients with solid malignancies (27%, 95% CI: 13–48%).</text>
 </g>
</svg>
